Loading clinical trials...
Loading clinical trials...
Early Investigation of Glucose Monitoring After Gestational Diabetes (ENGAGED): Utility and Acceptability of Continuous Glucose Monitoring in the Early Postpartum Period After Gestational Diabetes Mellitus
Conditions
Interventions
Continuous glucose monitor
Oral Glucose Tolerance Test
+1 more
Locations
1
United States
Ohio State University Medical Center
Columbus, Ohio, United States
Start Date
June 6, 2025
Primary Completion Date
May 30, 2026
Completion Date
May 30, 2027
Last Updated
January 22, 2026
NCT06925815
NCT07517406
NCT06648174
NCT06948825
NCT06445946
NCT05702931
Lead Sponsor
Ohio State University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions